METRO HOSPITALS & HEART INSTITUTE, HARIDWAR

Details
Medical Suppliers In Uttarakhand

Name :

METRO HOSPITALS & HEART INSTITUTE, HARIDWAR

Address  :

Plot No. F-1,
Sec-6A,
SIDCUL

Town  :

Haridwar

State  :

Uttarakhand

Country  :

INDIA

Phone  :

+91 133 4239040

Fax  :

+91 133 4239043

Web URL  :

Available

Email  :

metroharidwar@metrohospitals.com
METRO HOSPITALS HEART INSTITUTE HARIDWAR
Specialization
Information not available, if you are owner/employee of METRO HOSPITALS & HEART INSTITUTE, HARIDWAR Please click to update hospital details.
Facilities

ICU Beds : 8

Ward Beds : 60

Total Number Of Beds : 379

Ambulance Contact Number : +91 81919 02600

Description
With a mission to set more such dedicated centers for providing wholesome treatment to the patients all over the country Metro has established a 375 bedded Superspeciality hospital titled by Metro Hospital amp Heart Institute in Sidcul Haridwar with the aim to deliver world class patient care services in a comprehensive manner to every individual with an emphasis on quality service excellence empathy and respect at most affordable cost Metro Hospital amp Heart Institute is built on a sprawling area of 16511 sqft It is easily accessible and environmentally sealed hospital to ensure optimum comfort Metro Haridwar is equipped by state of art of equipment ampcentrally air conditioned
Metro Hospital has 197 rooms 6delux 65single 116 double 6 triple amp 1 four bed room with all amenities 28 OPDs 7 Modular Operation Theaters 2 Cathlabs 12 Dialysis Unit with 24x7 Emergency amp Trauma centre 75 state of art Intensive care beds with most advanced diagnostic services inhouse pharmacy round the clock ambulance etc
NEWS
India has highest oral cancer cases tobacco guilty areca nut too

India has the dubious distinction of having the worlds largest number of oral cancer patients with an annual agestandardised incidence of 125 per 100000 says Dr Pankaj Chaturvedi Associate Professor Department of Head and Neck Oncology Tata Memorial Hospital Mumbai Oral cancer accounts for 94 per cent of all cancers in India oral cancer is not ... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More